|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45.65 CNY | +2.93% |
|
+6.88% | +37.29% |
| Jul. 07 | Haisco Pharmaceutical to Raise 1.37 Billion Yuan via Share Placement; Shares Slump 5% | MT |
| Jul. 02 | Haisco Pharmaceutical Gets Clinical Trial Nod for Muscle Dystrophy Drug | MT |
| Capitalization | 50.64B 7.06B 6.05B 5.63B 5.25B 9.67B 607B 10.77B 67.85B 25.72B 284B 26.49B 25.95B 1,042B | P/E ratio 2025 * |
90.1x | P/E ratio 2026 * | 68.5x |
|---|---|---|---|---|---|
| Enterprise value | 50.64B 7.06B 6.05B 5.63B 5.25B 9.67B 607B 10.77B 67.85B 25.72B 284B 26.49B 25.95B 1,042B | EV / Sales 2025 * |
11.4x | EV / Sales 2026 * | 9.4x |
| Free-Float |
22.24% | Yield 2025 * |
0.15% | Yield 2026 * | 0.1% |
More valuation ratios
* Estimated data
More news
More press releases
| 1 day | +2.93% | ||
| 1 week | +6.88% | ||
| Current month | +8.12% | ||
| 1 month | -1.72% | ||
| 3 months | +0.51% | ||
| 6 months | +41.55% | ||
| Current year | +37.29% |
| 1 week | 42 |  | 46.45 |
| 1 month | 40.7 | | 46.87 |
| Current year | 29.13 | | 48.89 |
| 1 year | 25.48 | | 48.89 |
| 3 years | 15.01 | | 48.89 |
| 5 years | 12.93 | | 48.89 |
| 10 years | 9.43 | | 48.89 |
| Manager | Title | Age | Since |
|---|---|---|---|
Xiu Lian Fan
CEO | Chief Executive Officer | 61 | 2019-03-25 |
Peng Duan
DFI | Director of Finance/CFO | 50 | 2016-10-20 |
Wei Zheng
PRN | Corporate Officer/Principal | 55 | 2006-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Jun Min Wang
CHM | Chairman | 57 | 2006-12-31 |
Wei Zheng
BRD | Director/Board Member | 55 | 2006-12-31 |
Xiu Lian Fan
BRD | Director/Board Member | 61 | 2006-12-31 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.93% | +6.88% | +46.50% | +170.28% | 6.86B | ||
| +0.80% | +3.42% | -15.72% | +144.53% | 712B | ||
| -0.05% | +1.00% | +4.63% | -10.74% | 378B | ||
| -0.48% | +2.07% | +12.47% | +27.31% | 340B | ||
| +0.98% | +0.46% | -54.78% | +9.62% | 305B | ||
| +0.35% | +0.23% | +1.14% | -20.39% | 259B | ||
| +0.21% | -1.21% | -3.63% | +19.02% | 237B | ||
| +2.03% | +4.35% | -13.03% | -1.06% | 219B | ||
| +0.37% | +3.42% | -34.51% | -10.88% | 209B | ||
| +0.60% | +1.39% | -10.22% | +20.95% | 159B | ||
| Average | +0.75% | +1.33% | -6.71% | +34.86% | 282.39B | |
| Weighted average by Cap. | +0.50% | +1.05% | -12.00% | +39.76% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 4.45B 620M 531M 494M 461M 849M 53.34B 946M 5.96B 2.26B 24.96B 2.33B 2.28B 91.51B | 5.39B 752M 644M 599M 559M 1.03B 64.66B 1.15B 7.22B 2.74B 30.25B 2.82B 2.76B 111B |
| Net income | 568M 79.2M 67.79M 63.12M 58.89M 108M 6.81B 121M 761M 288M 3.19B 297M 291M 11.68B | 743M 104M 88.72M 82.61M 77.08M 142M 8.91B 158M 996M 377M 4.17B 389M 381M 15.29B |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
5,337
Sector
Pharmaceuticals
Calendar
Aug. 22
- Q2 2025 Earnings Release
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-07-14 | 45.65 ¥ | +2.93% | 3,963,461 |
| 25-07-11 | 44.35 ¥ | -4.44% | 5,639,730 |
| 25-07-10 | 46.41 ¥ | +10.00% | 5,536,879 |
| 25-07-09 | 42.19 ¥ | -0.87% | 3,117,514 |
| 25-07-08 | 42.56 ¥ | -0.35% | 3,092,573 |
End-of-day quote Shenzhen S.E., July 13, 2025
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
45.65CNY
Average target price
59.54CNY
Spread / Average Target
+30.43%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 002653 Stock
Select your edition
All financial news and data tailored to specific country editions
